NCT06108479 2026-03-18Study of DF6215 in Patients With Advanced Solid TumorsDragonfly TherapeuticsPhase 1 Completed35 enrolled
NCT04585750 2026-03-12The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PMV Pharmaceuticals, IncPhase 1/2 Recruiting300 enrolled
NCT06525220 2026-02-23A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Merus B.V.Phase 3 Recruiting500 enrolled